FDA Blocks Nine More INDs; Cooperative Group Chairmen, DeVita Blast “Lack of Expertise”
In Brief: UICC Publishes International directory Of Cancer Centers; HSAs Still Worry NCI
It’s Official – UCLA Recognize As 19th Comprehensive Center
FDA Committee to Discuss Policy On Combinations
L.A. County Nears Crucial Decision On Construction Funds
Swiss Report On Radiotherapy Mortality Questioned
ACCC To Consider Cancer Act Changes HSA Problems
New Atlas Showing nonwhite Mortality Rates Available
Trending Stories
- Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Bhattacharya cancels NIH all-hands meeting
- In the Headlines: “There’s no one to stand up for NCI right now.”
- Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies - $180M in NCI grants have been terminated by Trump administration, systematic review finds